Skip to content
PIL Logo

Abilify Maintena 300mg & 400mg powder and solvent for prolonged-release suspension for injection

Last Updated on eMC 12-Jul-2016 View document  | Otsuka Pharmaceuticals (UK) Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12-Jul-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 4 - possible side effects

Updated on 01-Apr-2016 and displayed until 12-Jul-2016

Reasons for adding or updating:

  • Change to section 3 - how to take/use

Updated on 10-Jul-2015 and displayed until 01-Apr-2016

Reasons for adding or updating:

  • Change to section 4 - possible side effects

Updated on 20-Mar-2015 and displayed until 10-Jul-2015

Reasons for adding or updating:

  • Change to section 3 - how to take/use
  • Change to section 6 - what the product looks like and pack contents

Updated on 05-Feb-2015 and displayed until 20-Mar-2015

Reasons for adding or updating:

  • Change to information for healthcare professionals

Updated on 22-Jan-2015 and displayed until 05-Feb-2015

Reasons for adding or updating:

  • Change to information for healthcare professionals

Updated on 15-Apr-2014 and displayed until 22-Jan-2015

Reasons for adding or updating:

  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors

Updated on 08-Jan-2014 and displayed until 15-Apr-2014

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Otsuka Pharmaceuticals (UK) Ltd

Company image
Address

Gallions, Wexham Springs, Framewood Road, Wexham, SL3 6PJ, UK

Fax

+44 (0)20 8848 0529

Telephone

+44 (0)20 3747 5300

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

aripiprazole

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue